EUVIMEDEUVIMED entdecken
Crossref

Drug-Induced and Malignancy-Associated Neutrophilic Dermatoses in Patients with Hematologic Malignancies: A Single Institution Experience

Mallory deCampos-Stairiker, Shannon Kody, Gabrielle Meyers, Julia Maxson, Alex G Ortega-Loayza

Dermatology · 2024

DOI: 10.1159/000539565 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Dermatology, 2024. Verfasst von Mallory deCampos-Stairiker und 4 weiteren Autor:innen. Beteiligte Einrichtung: Oregon Health and Science University School of Medicine, Portland, Oregon, USA. Hauptthemen laut MEDLINE: Hematologic Neoplasms, Sweet Syndrome. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Neutrophilic dermatoses (NDs) often occur secondary to inflammatory conditions, medication exposure, and hematologic malignancy. While malignancy-associated NDs (MA-NDs) have been well reported among those with hematologic cancers, little is known about drug-induced NDs (DI-NDs) within this population. The objective of this study was to compare the presentations and outcomes of patients with hematologic malignancies who developed MA-NDs and DI-NDs.

Methods

Cases of ND occurring between 2013 and 2023 among those with hematologic malignancies were identified from the electronic medical records of our institution. Patient characteristics, recent medication exposures, cancer mutations, and disease outcomes were reviewed. Patients were categorized with DI-ND if they were recently exposed to one of four medications known to be commonly associated with ND or were otherwise categorized with MA-ND. We report a descriptive analysis of cases of DI-ND and MA-ND.

Results

We identified 52 patients with ND and co-occurring hematologic malignancy including 16 cases of DI-ND (30.8%) and 36 cases of MA-ND (69.2%). The most common ND in both groups was Sweet’s syndrome. Chronic underlying conditions including solid tumors, inflammatory disorders, chronic viral infection, and tobacco use were more common among those with MA-ND. Among those with DI-ND, tyrosine kinase inhibitors were the most commonly associated drugs (43.8%). The most common cancer mutation among those with DI-ND was FLT3 (43.8%), while the most common mutation among those with MA-ND was TP-53 (19.4%). Among those who had died at the time of data collection, 90.0% of those with DI-ND and 66.7% of those with MA-ND died within 1 year of ND diagnosis.

Conclusion

Most cases of ND occurring with hematologic malignancies develop secondary to cancer rather than drug exposure. Different cancer mutations may predispose to DI-ND and MA-ND. Further research is needed to establish diagnostic criteria for DI-ND and to determine the pathogenic role of specific cancer mutations, particularly FLT3, in the development of ND.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematologic NeoplasmsSweet SyndromeHumansFemaleMaleMiddle AgedAgedRetrospective StudiesAdultAged, 80 and overDrug EruptionsNeutrophilsAntineoplastic Agents

Stichwörter der Autor:innen

Hematologic malignancyLeukemiaLymphomaNeutrophilic dermatosis

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Oregon Health and Science University School of Medicine, Portland, Oregon, USA.
  • Oregon Health and Science University Department of Dermatology, Portland, Oregon, USA.
  • Oregon Health and Science University Knight Cancer Institute, Portland, Oregon, USA.

Zitieren

APA

deCampos-Stairiker, M., Kody, S., Meyers, G., Maxson, J., & Ortega-Loayza, A. G. (2024). Drug-Induced and Malignancy-Associated Neutrophilic Dermatoses in Patients with Hematologic Malignancies: A Single Institution Experience. Dermatology. https://doi.org/10.1159/000539565

Vancouver

deCampos-Stairiker M, Kody S, Meyers G, Maxson J, Ortega-Loayza AG. Drug-Induced and Malignancy-Associated Neutrophilic Dermatoses in Patients with Hematologic Malignancies: A Single Institution Experience. Dermatology. 2024. doi:10.1159/000539565

BibTeX
@article{deCamposStairiker2024,
  author = {deCampos-Stairiker, Mallory and Kody, Shannon and Meyers, Gabrielle and Maxson, Julia and Ortega-Loayza, Alex G},
  title = {Drug-Induced and Malignancy-Associated Neutrophilic Dermatoses in Patients with Hematologic Malignancies: A Single Institution Experience},
  journal = {Dermatology},
  year = {2024},
  doi = {10.1159/000539565}
}
Kostenlos starten →